| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.007 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.083 | 0.008 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |